iRhythm Technologies Inc (IRTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iRhythm Technologies Inc (IRTC) has a cash flow conversion efficiency ratio of 0.172x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($26.21 Million) by net assets ($152.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
iRhythm Technologies Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how iRhythm Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read iRhythm Technologies Inc total liabilities for a breakdown of total debt and financial obligations.
iRhythm Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iRhythm Technologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BrightGene Bio Medical Technology C
SHG:688166
|
0.010x |
|
EO Technics Co. Ltd
KQ:039030
|
0.046x |
|
AUMOVIO N
XETRA:AMV0
|
N/A |
|
Tsinghuatongfang Co Ltd
SHG:600100
|
0.019x |
|
Chongqing Brewery Co Ltd
SHG:600132
|
0.242x |
|
Federated Investors Inc B
NYSE:FHI
|
0.082x |
|
Air Canada
TO:AC
|
0.163x |
|
FLSmidth & Co.
CO:FLS
|
0.047x |
Annual Cash Flow Conversion Efficiency for iRhythm Technologies Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of iRhythm Technologies Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see IRTC stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $152.75 Million | $80.86 Million | 0.529x | +1319.65% |
| 2024-12-31 | $90.91 Million | $3.39 Million | 0.037x | +115.64% |
| 2023-12-31 | $210.10 Million | $-50.10 Million | -0.238x | -148.51% |
| 2022-12-31 | $239.81 Million | $-23.01 Million | -0.096x | +28.95% |
| 2021-12-31 | $279.51 Million | $-37.75 Million | -0.135x | -235.35% |
| 2020-12-31 | $341.61 Million | $-13.76 Million | -0.040x | +75.05% |
| 2019-12-31 | $135.41 Million | $-21.86 Million | -0.161x | +69.77% |
| 2018-12-31 | $54.42 Million | $-29.07 Million | -0.534x | -184.96% |
| 2017-12-31 | $79.55 Million | $-14.91 Million | -0.187x | -4.19% |
| 2016-12-31 | $92.56 Million | $-16.65 Million | -0.180x | -201.53% |
| 2015-12-31 | $-101.62 Million | $-18.00 Million | 0.177x | +108.24% |
| 2014-12-31 | $7.26 Million | $-15.63 Million | -2.151x | +16.49% |
| 2013-12-31 | $4.60 Million | $-11.85 Million | -2.576x | -- |
About iRhythm Technologies Inc
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more